EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Efficacy of statins in preventing anthracycline-induced cardiotoxicity in individuals with breast cancer: a systematic review and meta-analysis

Internal Medicine, Bayhealth Medical Center

The Journal of Clinical Oncology · 24.10.2025 · 13 (1)

DOI: 10.52338/tjoco.2025.4970 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift The Journal of Clinical Oncology, online erschienen am 24.10.2025. Verfasst von Internal Medicine und 1 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Anthracyclines are standard chemotherapeutic agents for breast cancer but may cause dose-dependent, irreversible myocardial damage (class I cardiotoxicity) via reactive oxygen species (ROS), potentially leading to dilated cardiomyopathy and heart failure. Statins, through their pleiotropic effects, reduce oxidative stress and inflammation, offering cardioprotection. This meta-analysis evaluates the impact of statins on cardiac dysfunction, LVEF, LVESV, LVEDV, and LA diameter in women with breast cancer receiving anthracycline-based chemotherapy.

Methods

PubMed, Google Scholar, and Cochrane Library were searched through February 11, 2025, for randomized controlled trials and propensity-matched observational studies comparing statins with placebo in breast cancer patients on anthracyclines. Outcomes included changes in cardiac dysfunction, LVEF, LVESV, LVEDV, and LA diameter. A review manager was used to analyze data as mean differences with 95% confidence intervals (CI).

Results

A total of 428 patients were included; 180 (42%) in the statin group and 248 (58%) in the placebo group. Statin users had a significantly lower risk of cardiac dysfunction (RR=0.41 [95% CI: 0.23–0.72], P=0.02, I²=0%). They also had reduced LVEF decline (MD= -3.42 [CI: -5.10 to -1.73], P

Zitieren

APA

Medicine, I., & Center, B. M. (2025). Efficacy of statins in preventing anthracycline-induced cardiotoxicity in individuals with breast cancer: a systematic review and meta-analysis. The Journal of Clinical Oncology, 13(1). https://doi.org/10.52338/tjoco.2025.4970

Vancouver

Medicine I, Center BM. Efficacy of statins in preventing anthracycline-induced cardiotoxicity in individuals with breast cancer: a systematic review and meta-analysis. The Journal of Clinical Oncology. 2025;13(1). doi:10.52338/tjoco.2025.4970

BibTeX
@article{Medicine2025,
  author = {Medicine, Internal and Center, Bayhealth Medical},
  title = {Efficacy of statins in preventing anthracycline-induced cardiotoxicity in individuals with breast cancer: a systematic review and meta-analysis},
  journal = {The Journal of Clinical Oncology},
  year = {2025},
  volume = {13},
  number = {1},
  doi = {10.52338/tjoco.2025.4970}
}
Kostenlos starten →